These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 36169637)
21. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor. Fischedick J; Van Der Kooy F; Verpoorte R Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579 [TBL] [Abstract][Full Text] [Related]
22. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys. Carey LM; Maguire DR; France CP Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805 [TBL] [Abstract][Full Text] [Related]
23. Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints? Freeman TP; Morgan CJ; Hindocha C; Schafer G; Das RK; Curran HV Addiction; 2014 Oct; 109(10):1686-94. PubMed ID: 24894801 [TBL] [Abstract][Full Text] [Related]
24. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration. Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060 [TBL] [Abstract][Full Text] [Related]
25. Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats. Durbin DJ; King JM; Stairs DJ Cannabis Cannabinoid Res; 2024 Apr; 9(2):601-611. PubMed ID: 36802211 [No Abstract] [Full Text] [Related]
26. The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ Geci M; Scialdone M; Tishler J Cannabis Cannabinoid Res; 2023 Apr; 8(2):270-282. PubMed ID: 36264171 [No Abstract] [Full Text] [Related]
27. Potency trends of cannabis in Jamaica during the period of 2014 to 2020. Lindsay CM; Bernard KK; Hammond AM; Beckford S; Abel WD; Brown PD; Young LE Drug Test Anal; 2024 Feb; 16(2):174-186. PubMed ID: 37309060 [TBL] [Abstract][Full Text] [Related]
28. UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers. Lo Faro AF; Tini A; Gottardi J; Pichini S; Carlier J; Giorgetti R; Busardò FP J Anal Toxicol; 2023 Jan; 46(9):e256-e261. PubMed ID: 36214389 [TBL] [Abstract][Full Text] [Related]
29. External hair contamination from cannabis and "light cannabis" delivered by smoking and vaping: An in vitro study. Giorgetti A; Fais P; Pascali JP; Mohamed S; Rossi F; Garagnani M; Pelletti G Drug Test Anal; 2024 Oct; 16(10):1077-1084. PubMed ID: 38145896 [TBL] [Abstract][Full Text] [Related]
30. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil. Carvalho VM; de Almeida FG; de Macêdo Vieira AC; Rocha ED; Cabral LM; Strongin RM Forensic Sci Int; 2022 Jun; 335():111309. PubMed ID: 35462181 [TBL] [Abstract][Full Text] [Related]
31. Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry. Poklis JL; Thompson CC; Long KA; Lichtman AH; Poklis A J Anal Toxicol; 2010 Oct; 34(8):516-20. PubMed ID: 21258613 [TBL] [Abstract][Full Text] [Related]
32. Potency of Δ Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730 [TBL] [Abstract][Full Text] [Related]
33. Vapor inhalation of cannabidiol (CBD) in rats. Javadi-Paydar M; Creehan KM; Kerr TM; Taffe MA Pharmacol Biochem Behav; 2019 Sep; 184():172741. PubMed ID: 31336109 [TBL] [Abstract][Full Text] [Related]
34. Public interest in ∆ Leas EC; Nobles AL; Shi Y; Hendrickson E Int J Drug Policy; 2022 Mar; 101():103557. PubMed ID: 34952279 [TBL] [Abstract][Full Text] [Related]
35. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis. Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009 [TBL] [Abstract][Full Text] [Related]
36. Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products. Nemeškalová A; Hájková K; Mikulů L; Sýkora D; Kuchař M Talanta; 2020 Nov; 219():121250. PubMed ID: 32887141 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive cannabinoid profiling of acid-treated CBD samples and Δ Huang S; van Beek TA; Claassen FW; Janssen HG; Ma M; Chen B; Zuilhof H; Salentijn GI Food Chem; 2024 May; 440():138187. PubMed ID: 38134831 [TBL] [Abstract][Full Text] [Related]
38. Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature. Golombek P; Müller M; Barthlott I; Sproll C; Lachenmeier DW Toxics; 2020 Jun; 8(2):. PubMed ID: 32503116 [TBL] [Abstract][Full Text] [Related]
39. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products. Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]